Silke Hansen

1.3k total citations
18 papers, 1.0k citations indexed

About

Silke Hansen is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Silke Hansen has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 5 papers in Biotechnology. Recurrent topics in Silke Hansen's work include Cancer-related Molecular Pathways (14 papers), RNA modifications and cancer (5 papers) and Cancer Research and Treatments (5 papers). Silke Hansen is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), RNA modifications and cancer (5 papers) and Cancer Research and Treatments (5 papers). Silke Hansen collaborates with scholars based in Germany, United Kingdom and Switzerland. Silke Hansen's co-authors include Christian Klein, David P. Lane, Johannes Büchner, Stefan Bell, L. Müller, Ted R. Hupp, Richard A. Engh, Klaus‐Peter Künkele, Friederike Hesse and Raphael Stoll and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Molecular Biology.

In The Last Decade

Silke Hansen

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Hansen Germany 14 814 663 168 105 100 18 1.0k
Penka V. Nikolova United Kingdom 18 1.1k 1.4× 700 1.1× 187 1.1× 87 0.8× 42 0.4× 28 1.4k
Alexander Dehner Germany 10 588 0.7× 332 0.5× 76 0.5× 48 0.5× 63 0.6× 12 732
Paola Di Lello United States 19 855 1.1× 379 0.6× 43 0.3× 97 0.9× 91 0.9× 33 1.2k
Brett Lovejoy United States 9 756 0.9× 430 0.6× 77 0.5× 55 0.5× 94 0.9× 10 1.2k
Örjan Zetterqvist Sweden 21 1.1k 1.4× 361 0.5× 49 0.3× 193 1.8× 90 0.9× 46 1.5k
Brian S. DeDecker United States 11 989 1.2× 473 0.7× 109 0.6× 67 0.6× 17 0.2× 13 1.2k
Michael F. T. Koehler United States 15 640 0.8× 168 0.3× 98 0.6× 152 1.4× 231 2.3× 21 936
Guixian Jin United States 15 714 0.9× 264 0.4× 35 0.2× 61 0.6× 108 1.1× 21 1.1k
Zoltán Szeltner Hungary 22 791 1.0× 765 1.2× 56 0.3× 23 0.2× 90 0.9× 40 1.3k
James Rosinski United States 8 843 1.0× 483 0.7× 87 0.5× 73 0.7× 39 0.4× 12 1.1k

Countries citing papers authored by Silke Hansen

Since Specialization
Citations

This map shows the geographic impact of Silke Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Hansen more than expected).

Fields of papers citing papers by Silke Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Hansen. The network helps show where Silke Hansen may publish in the future.

Co-authorship network of co-authors of Silke Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Hansen. A scholar is included among the top collaborators of Silke Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Hansen. Silke Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Dengl, Stefan, Harald Dürr, Klaus Kaluza, et al.. (2011). Allosteric antibody inhibition of human hepsin protease. Biochemical Journal. 442(3). 483–494. 23 indexed citations
3.
Janczyk, Paweł, Silke Hansen, Mahtab Bahramsoltani, & Johanna Plendl. (2010). The glycocalyx of human, bovine and murine microvascular endothelial cells cultured in vitro. Journal of Electron Microscopy. 59(4). 291–298. 18 indexed citations
4.
Dehner, Alexander, Christian Klein, Silke Hansen, et al.. (2005). Cooperative Binding of p53 to DNA: Regulation by Protein–Protein Interactions through a Double Salt Bridge. Angewandte Chemie International Edition. 44(33). 5247–5251. 44 indexed citations
5.
Dehner, Alexander, Christian Klein, Silke Hansen, et al.. (2005). Kooperative Bindung von p53 an DNA: Regulation durch Protein‐Protein‐Wechselwirkung unter Bildung einer doppelten Salzbrücke. Angewandte Chemie. 117(33). 5381–5386. 4 indexed citations
6.
Klein, Christian, Friederike Hesse, Alexander Dehner, et al.. (2004). In vitro folding and characterization of the p53 DNA binding domain. Biological Chemistry. 385(1). 95–102. 5 indexed citations
7.
Bell, Stefan, Christian Klein, L. Müller, Silke Hansen, & Johannes Büchner. (2002). p53 Contains Large Unstructured Regions in its Native State. Journal of Molecular Biology. 322(5). 917–927. 213 indexed citations
8.
Bell, Stefan, Silke Hansen, & Johannes Büchner. (2002). Refolding and structural characterization of the human p53 tumor suppressor protein. Biophysical Chemistry. 96(2-3). 243–257. 33 indexed citations
9.
Klein, Christian, Eckart Planker, Tammo Diercks, et al.. (2001). NMR Spectroscopy Reveals the Solution Dimerization Interface of p53 Core Domains Bound to Their Consensus DNA. Journal of Biological Chemistry. 276(52). 49020–49027. 76 indexed citations
10.
Klein, Christian, Guy Georges, Klaus‐Peter Künkele, et al.. (2001). High Thermostability and Lack of Cooperative DNA Binding Distinguish the p63 Core Domain from the Homologous Tumor Suppressor p53. Journal of Biological Chemistry. 276(40). 37390–37401. 66 indexed citations
11.
Stoll, Raphael, Christian Renner, Silke Hansen, et al.. (2000). Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53. Biochemistry. 40(2). 336–344. 246 indexed citations
12.
Hansen, Silke, et al.. (1999). Burns. Handle with care.. PubMed. 62(11). 52–7; quiz 58. 1 indexed citations
13.
Hansen, Silke, David P. Lane, & Carol Midgley. (1998). The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability 1 1Edited by J. Karn. Journal of Molecular Biology. 275(4). 575–588. 35 indexed citations
14.
Mundt, Maren, Ted R. Hupp, Michael Fritsche, et al.. (1997). Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene. 15(2). 237–244. 46 indexed citations
15.
Hansen, Silke, Ted R. Hupp, & David P. Lane. (1996). Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting Proteins. Journal of Biological Chemistry. 271(7). 3917–3924. 83 indexed citations
16.
Hansen, Silke, Carol Midgley, David P. Lane, et al.. (1996). Modification of Two Distinct COOH-terminal Domains Is Required for Murine p53 Activation by Bacterial Hsp70. Journal of Biological Chemistry. 271(48). 30922–30928. 25 indexed citations
17.
Hansen, Silke, et al.. (1996). Oxidative stress is involved in the UV activation of p53. Journal of Cell Science. 109(5). 1105–1112. 100 indexed citations
18.
Stoll, Raphael, Christian Renner, Silke Hansen, et al.. (1995). Sequence-specific 1H, 15N, and 13C assignment of the N-terminal domain of the human oncoprotein MDM2 that binds to p53. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026